Morphic Holding Inc [MORF] stock prices are up 7.04% to $38.16 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MORF shares have gain 6.24% over the last week, with a monthly amount glided 26.15%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 22, February 2024, Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023. In a post published today on Yahoo Finance, -Reported positive results from EMERALD-1 phase 2a trial of MORF-057 in ulcerative colitis (UC)-.
From an analyst’s perspective:
Morphic Holding Inc [NASDAQ: MORF] stock has seen the most recent analyst activity on December 08, 2023, when Citigroup initiated its Buy rating and assigned the stock a price target of $46. Previously, Stifel reaffirmed its Hold rating on September 25, 2023, and dropped its price target to $33. On September 25, 2023, downgrade downgraded it’s rating to Neutral. Stifel downgraded its rating to a Hold and decreased its price target to $61 on August 09, 2023. Stifel initiated its recommendation with a Buy and recommended $44 as its price target on September 07, 2022. SVB Leerink started tracking with a Outperform rating for this stock on July 20, 2022, and assigned it a price target of $45. In a note dated March 31, 2022, Canaccord Genuity initiated an Buy rating and provided a target price of $68 on this stock.
The stock price of Morphic Holding Inc [MORF] has been fluctuating between $19.34 and $63.08 over the past year. Morphic Holding Inc [NASDAQ: MORF] shares were valued at $38.16 at the most recent close of the market.
Analyzing the MORF fundamentals
The Morphic Holding Inc [NASDAQ:MORF] reported sales of 0.52M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.35 points at the first support level, and at 34.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 39.15, and for the 2nd resistance point, it is at 40.14.
Morphic Holding Inc [MORF] reported earnings per share of -$0.96 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.85/share, meaning a difference of -$0.11 and a surprise factor of -12.90%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.73 per share as compared to estimates of -$0.95 per share, a difference of $0.22 representing a surprise of 23.20%.
Ratios To Look Out For
It’s worth pointing out that Morphic Holding Inc [NASDAQ:MORF]’s Current Ratio is 28.94. In addition, the Quick Ratio stands at 28.94 and the Cash Ratio stands at 0.05. Considering the valuation of this stock, the price to sales ratio is 3672.17, the price to book ratio is 2.72.
Transactions by insiders
Recent insider trading involved Tipirneni Praveen P., CEO, that happened on Jan 16 when 13923.0 shares were sold. President, Rogers Bruce completed a deal on Jan 16 to sell 6314.0 shares. Meanwhile, CFO and COO SCHEGERIN MARC sold 6041.0 shares on Jan 16.
